Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects.
Open Access
- 1 March 1984
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 73 (3), 816-823
- https://doi.org/10.1172/jci111276
Abstract
Two major species of human apolipoprotein (apo) B have been identified, apo B-48 and apo B-100, which are the predominant forms in chylomicrons and very low density lipoproteins (VLDL), respectively. Due to defective hepatic clearance, apo B-48 containing lipoproteins accumulate in the plasma of subjects with type III hyperlipoproteinemia. In the present study, we have used immunoaffinity chromatography to separate type III VLDL into a nonretained (apo B-48 VLDL) and a retained (apo B-100 VLDL) fraction. To achieve complete separation, as determined by electrophoresis and radioimmunoassay, it was necessary to employ two different insolubilized anti-apo B-100 monoclonal antibodies because of immunochemical heterogeneity within the apo B-100 VLDL fraction. The ability to separate apo B-100 VLDL from apo B-48 VLDL shows that the two apo B species are found on different particles. The apo B-48 VLDL had an electrophoretic mobility similar to chylomicrons, whereas the apo B-100 VLDL migrated similarly to total type III VLDL. Both fractions showed a concentration of particles with diameters approximately 100 nm, with apo B-48 VLDL being somewhat more heterogeneous in particle size. The two fractions were qualitatively similar in apolipoprotein composition but apo B-48 VLDL was enriched in apo E, relative to apo B-100 VLDL. Apo B-48 VLDL was enriched in cholesterol esters and deficient in triglycerides and phospholipids when compared with apo B-100 VLDL. The existence of immunochemical heterogeneity in the apo B-100 VLDL may reflect different functional subpopulations of particles within this fraction.This publication has 46 references indexed in Scilit:
- Cholesteryl ester and apolipoprotein E transfer between human high density lipoproteins and chylomicronsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983
- Characterization of monoclonal antibodies against human low density lipoprotein.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1983
- Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1983
- Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.Journal of Clinical Investigation, 1981
- Normotriglyceridemic abetalipoproteinemia. absence of the B-100 apolipoprotein.Journal of Clinical Investigation, 1981
- Synthesis of two forms of apolipoprotein B by cultured rat hepatocytesBiochemical and Biophysical Research Communications, 1981
- Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat.Journal of Clinical Investigation, 1980
- Lipolysis Produces Changes in the Immunoreactivity and Cell Reactivity of Very Low Density LipoproteinsJournal of Clinical Investigation, 1979
- Comparison of the serum low density lipoprotein and of its apoprotein in the pig, rhesus monkey and baboon with that in manAtherosclerosis, 1976
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955